Goldman Sachs Reiterates Sell on Dolby Laboratories (DLB)
Goldman Sachs is out with its report on Dolby Laboratories (NYSE: DLB), reiterating Sell.
In a note to clients, Goldman Sachs writes, "We reiterate our Sell rating on Dolby shares as we believe the company is transitioning from a high growth company, growing EPS at 30% plus rates, to a company that will grow slightly better than the overall market, implying it should trade closer to market multiples."
Shares of DLB closed Wednesday at $49.87, down 0.80% from Tuesday's close.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Dolby Laboratories Goldman SachsAnalyst Color Analyst Ratings